Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
(2016) In Scandinavian Journal of Urology 50(4). p.255-259- Abstract
Objective: The aim of this study was to create a model for predicting progression-free survival after radical prostatectomy for localized prostate cancer. Material and methods: The risk of biochemical recurrence (BCR) was modelled in a cohort of 3452 men aged 70 years or younger who were primarily treated with radical prostatectomy after being diagnosed between 2003 and 2006 with localized prostate cancer [clinical stage T1c–T2, Gleason score 5–10, N0/NX, M0/MX, prostate-specific antigen (PSA)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/eb016806-2ec2-4f0f-a71e-5bbd42b83b3d
- author
- Bjartell, Anders LU ; Bottai, Matteo ; Persson, Josefin ; Bratt, Ola LU ; Damber, Jan Erik ; Stattin, Pär and Akre, Olof
- organization
- publishing date
- 2016-07-03
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Biochemical recurrence, nomogram, predictive models, prostate cancer, radical prostatectomy
- in
- Scandinavian Journal of Urology
- volume
- 50
- issue
- 4
- pages
- 255 - 259
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:84969172459
- pmid:27192553
- wos:000379024000003
- ISSN
- 2168-1805
- DOI
- 10.1080/21681805.2016.1183226
- language
- English
- LU publication?
- yes
- id
- eb016806-2ec2-4f0f-a71e-5bbd42b83b3d
- date added to LUP
- 2016-05-31 15:41:13
- date last changed
- 2024-05-17 07:25:21
@article{eb016806-2ec2-4f0f-a71e-5bbd42b83b3d, abstract = {{<p>Objective: The aim of this study was to create a model for predicting progression-free survival after radical prostatectomy for localized prostate cancer. Material and methods: The risk of biochemical recurrence (BCR) was modelled in a cohort of 3452 men aged 70 years or younger who were primarily treated with radical prostatectomy after being diagnosed between 2003 and 2006 with localized prostate cancer [clinical stage T1c–T2, Gleason score 5–10, N0/NX, M0/MX, prostate-specific antigen (PSA) </p>}}, author = {{Bjartell, Anders and Bottai, Matteo and Persson, Josefin and Bratt, Ola and Damber, Jan Erik and Stattin, Pär and Akre, Olof}}, issn = {{2168-1805}}, keywords = {{Biochemical recurrence; nomogram; predictive models; prostate cancer; radical prostatectomy}}, language = {{eng}}, month = {{07}}, number = {{4}}, pages = {{255--259}}, publisher = {{Taylor & Francis}}, series = {{Scandinavian Journal of Urology}}, title = {{Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort}}, url = {{http://dx.doi.org/10.1080/21681805.2016.1183226}}, doi = {{10.1080/21681805.2016.1183226}}, volume = {{50}}, year = {{2016}}, }